Gynecologic postoperative anti-adhesion barriers: From biomaterials to barrier development

Area of Science:

• Biomaterials Science
• Gynecologic Surgery
• Reproductive Medicine

Background:

• Gynecologic postoperative adhesions (GPOA) are a significant cause of morbidity, affecting up to 90% of patients after procedures like myomectomy or endometriosis excision.
• These adhesions contribute to secondary infertility, chronic pelvic pain, bowel obstruction, and severe obstetric complications.
• Existing anti-adhesion barriers require enhanced biocompatibility, specific resorption profiles, and proven safety for gynecologic applications due to the unique hormonal and reproductive context of the female pelvis.

Purpose of the Study:

• To review and consolidate the literature on advanced biomaterial-based barriers specifically designed for preventing gynecologic postoperative adhesions.
• To highlight the unique design considerations for gynecologic anti-adhesion barriers, including biocompatibility, resorption timing, teratogenic safety, and reproductive regulatory classification.
• To identify opportunities for next-generation gynecologic adhesion barriers that are multifunctional, patient-specific, and suitable for minimally invasive deployment.

Main Methods:

• Dissection of the pathophysiology of uterine and adnexal adhesion formation, focusing on mesothelial disruption, fibrin persistence, and estrogen-modulated wound healing.
• Critical appraisal of natural and synthetic polymers used in barrier formulations, examining their in-vivo elimination and impact on fertility.
• Review of cutting-edge fabrication strategies like electrospinning, 3D bioprinting, and microneedle patches for gynecologic barrier development.

Main Results:

• The pathophysiology of adhesion formation presents specific targets for barrier design in the female reproductive tract.
• Formulation parameters of natural and synthetic polymers significantly influence barrier performance and fertility outcomes.
• Advanced fabrication techniques offer potential for improved uterine conformity, deployability, and drug delivery capabilities.

Conclusions:

• Next-generation gynecologic anti-adhesion barriers require tailored biomaterials and innovative fabrication methods.
• Addressing unmet needs in gynecologic adhesion prevention can reduce infertility, surgical re-admissions, and obstetric risks.
• A roadmap is provided for translating advanced barrier technologies from research to clinical practice for improved women's health outcomes.